Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

CD2 might be a new treatment target for patchy alopecia areata.

More research is needed to understand and manage rheumatoid arthritis better.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Targeting specific cell interactions may help treat skin fibrosis.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

Homeopathic treatment can help manage alopecia areata in children.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Blocking LFA-1 prevents hair loss in mice.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Abatacept may help some people with alopecia areata regrow hair.

Targeting Vδ1+T-cells may help treat alopecia areata.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Hair follicles prevent NK cell attacks to avoid hair loss.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

ILC1-like cells can independently cause alopecia areata.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.